CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Inovio Pharmaceuticals, Inc. - INO CFD

4.1539
3.88%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0522
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024318 %
Charges from full value of position ($-4.62)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024318%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002096 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002096%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.001
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.9989
Open 3.9939
1-Year Change 982.65%
Day's Range 3.9939 - 4.2039
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 6, 2024 4.1539 0.1500 3.75% 4.0039 4.2139 3.9839
Dec 5, 2024 3.9989 -0.0850 -2.08% 4.0839 4.0939 3.9339
Dec 4, 2024 4.1089 -0.0550 -1.32% 4.1639 4.2089 4.0889
Dec 3, 2024 4.1689 -0.1750 -4.03% 4.3439 4.5839 4.1289
Dec 2, 2024 4.3289 -0.0050 -0.12% 4.3339 4.5139 4.2839
Nov 29, 2024 4.2989 0.1150 2.75% 4.1839 4.3089 4.1839
Nov 27, 2024 4.1689 0.1450 3.60% 4.0239 4.2189 4.0239
Nov 26, 2024 3.9889 -0.1150 -2.80% 4.1039 4.2239 3.9739
Nov 25, 2024 4.1089 0.0750 1.86% 4.0339 4.2389 4.0189
Nov 22, 2024 4.0589 0.0350 0.87% 4.0239 4.1939 4.0039
Nov 21, 2024 4.0389 0.0750 1.89% 3.9639 4.2139 3.9489
Nov 20, 2024 3.9489 0.0150 0.38% 3.9339 4.0989 3.8989
Nov 19, 2024 4.0189 0.0350 0.88% 3.9839 4.1789 3.8239
Nov 18, 2024 4.0489 -0.0950 -2.29% 4.1439 4.1639 4.0489
Nov 15, 2024 4.2389 -0.6250 -12.85% 4.8639 4.8639 4.1789
Nov 14, 2024 4.7789 -0.1550 -3.14% 4.9339 5.0239 4.7389
Nov 13, 2024 4.9389 -0.2050 -3.99% 5.1439 5.2339 4.9189
Nov 12, 2024 5.1289 -0.1150 -2.19% 5.2439 5.3139 5.0789
Nov 11, 2024 5.3189 -0.2150 -3.89% 5.5339 5.5539 5.2389
Nov 8, 2024 5.5189 0.0350 0.64% 5.4839 5.5539 5.4139

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Inovio Pharmaceuticals Company profile

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system''s tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; QIAGEN N.V.; Coalition for Epidemic Preparedness Innovations; and Beijing Advaccine Biotechnology Co. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Industry: Biotechnology & Medical Research (NEC)

6769 Mesa Ridge Rd.
SAN DIEGO
CALIFORNIA 92121
US

People also watch

BTC/USD

100,192.45 Price
-0.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

2.60 Price
+8.300% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01298

Oil - Crude

67.04 Price
-1.760% 1D Chg, %
Long position overnight fee 0.0057%
Short position overnight fee -0.0277%
Overnight fee time 22:00 (UTC)
Spread 0.030

Gold

2,633.54 Price
+0.050% 1D Chg, %
Long position overnight fee -0.0168%
Short position overnight fee 0.0086%
Overnight fee time 22:00 (UTC)
Spread 0.60

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading